Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Omega Diagnostics falls; Venture Life sales up

Mon, 31st Jan 2022 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Venture Life Group PLC, up 28% at 48.00 pence, 12-month range 27.00p-105.00p. The maker of self-care products expects to report a revenue rise of 8.3% to GBP32.6 million in 2021 from GBP30.1 million in 2020. Revenue increased by 35% to GBP18.7 million in the second half from GBP13.9 million in the first half. The Berkshire-based company develops products such as Dentyl mouthwash and Rosa Calma rosacea treatment range.

----------

Next Fifteen Communications Group PLC, up 12% at 1,215.00 pence, 12-month range 600.00p-1,350.00p. The media and marketing firm says revenue surges 34% in both the fourth quarter and the full year, which concludes on Monday. Results are ahead of market expectations and set up Next Fifteen for a "positive start to our new financial year", despite tough comparatives.

----------

AIM - LOSERS

----------

Omega Diagnostics Group PLC, down 26% at 7.86p, 12-month range 6.75p-117.98p. The Alva, Scotland-based medical diagnostics company confirms it is in talks with investors over a possible equity raise, following "recent online speculation". Omega says any cash raise will come at a discount but adds there is "no immediate need to raise additional capital". Shares hit the 12-month low on Monday.

----------

Tanfield Group PLC, down 10% at 2.02p, 12-month range 1.90p-3.96p. The investment firm says a delay by investee Snorkel in producing documents in US legal proceedings means a trial will be delayed. The US trial window is not expected to begin until August at the earliest. Back in October 2019, Tanfield said both Snorkel and and SKL Holdings LLC filed a summons and complaint against Tanfield. Tanfield has a 49% stake in Snorkel under its joint venture with Xtreme Manufacturing LLC. In November 2018, SKL exercised a call option for Tanfield's Snorkel interest at an option price of nothing. SKL also claimed it did not have to pay the priority amount and preferred return on the Snorkel stake. Tanfield disagreed, rejecting the call option notice's validity.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Sep 2021 12:39

IN BRIEF: Omega Diagnostics awaits approval for home use of Visitect

IN BRIEF: Omega Diagnostics awaits approval for home use of Visitect

Read more
6 Sep 2021 12:04

Omega Diagnostics files for CE-mark on Covid-19 self-test

(Sharecast News) - Medical diagnostics company Omega announced on Monday that all of the supporting data and documentation relating to its submission for CE-marking for self-test use of its 'Visitect' Covid-19 antigen test had been filed with its European notified body.

Read more
13 Jul 2021 15:05

Omega Diagnostics annual loss narrows; finance director leaves

Omega Diagnostics annual loss narrows; finance director leaves

Read more
6 Jul 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Jul 2021 11:41

AIM WINNERS & LOSERS: Microsaic up on new mass spectrometry technology

AIM WINNERS & LOSERS: Microsaic up on new mass spectrometry technology

Read more
2 Jul 2021 10:14

Omega Diagnostics Covid antigen test takes step closer to US approval

Omega Diagnostics Covid antigen test takes step closer to US approval

Read more
8 Jun 2021 14:29

IN BRIEF: Omega Diagnostics tests seek regulator approval in US and EU

IN BRIEF: Omega Diagnostics tests seek regulator approval in US and EU

Read more
8 Jun 2021 09:26

Omega Diagnostics progresses Covid-19 test with EU, US regulators

(Sharecast News) - Medical diagnostics company Omega updated the market on regulatory approvals for the 'Visitect' Covid-19 antigen test on Tuesday, confirming that it has started engaging with its European notified body, seeking CE-marking of the test.

Read more
7 Jun 2021 17:59

TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent

TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent

Read more
7 Jun 2021 10:36

Omega still waiting on government for Covid-19 test manufacture details

(Sharecast News) - Medical diagnostics company Omega updated the market on its UK government manufacturing contract on Monday, reporting that it remained in regular dialogue with the Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests.

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
30 Apr 2021 13:35

Omega Diagnostics launches Visitect Covid-19 antigen test

(Sharecast News) - Omega Diagnostics announced the launch of its 'Visitect' Covid-19 antigen test on Friday, which it described as a rapid point-of-care diagnostic test for the detection of active Covid-19 infections.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.